As expected, colonization of GF IL-10−/− mice with human CD microbiota induced more significant histologic inflammation than those inoculated with control microbiota, consistent with the established hypothesis that manifestation of clinical IBD requires a genetic predisposition in addition to immune activation by intestinal microbiotia (3). This evidence concerns the gene IL10 and inflammatory bowel disease.